50 Followers SGX:T14 - Tianjin ZX USD (USD 0.795) TIANJIN ZHONG XIN PHARM GROUP
Sector: Health Technology, Industry: Pharmaceuticals: Other

Add to WatchList

USD 0.795    +0.005 (+0.63%)
Show Basic Chart | 3M    6M    1Y    3Y    5Y          

20 Feb 2020


20 Feb 2020

52 Wk Range: 0.76 - 1.05

Day's Range: 0.79 - 0.805

Last Volume: 163,900

Current Yield: 4.03%

Projected Yield: 3.95%

Future Yield: [Friends Only]

Dividend Strength: [Friends Only]

20 Feb 2020

Metric T14 S.Median
Beta 0.71 0.05
VaR 18.42 35.78
E.Shortfall 22.13 52.26
Liquidity 109.06K 30.25K


19 Feb 2020

PE: 6.87

Market Cap: 610.5M

Price Over Book: 0.833

Price Over Sales: 0.62

Return On Assets: 8.5%

Return On Equity: 12.5%

NAV Over Price: [Friends Only]


CEO: Yan Li

Founded Year: 1992

Headquarters: Tianjin

Employees: 4,642

Shares Outstanding: 772.8M

Security Type: Stock

Useful Links


Tianjin Zhong Xin Pharmaceutical Group Corp. Ltd. engages in the manufacture and sale of traditional Chinese medicine. Its business covers proprietary Chinese medicines, Chinese herbal medicines, chemical raw materials and preparations, biomedicine, nutritional supplements research and development and manufacturing, and commercial medicine. Its products include cardiovascular medicine, respiratory medicine, spleen and stomach medicine, cold medicine, cancer medication, gynecology, pediatrics and other multi-product groups. The company was founded on December 20, 1992 and is headquartered in Tianjin, China.